KRS Capital Management, LLC
Source: SEC Form 13F · as of Mar 2026KRS Capital Management, LLC holds 13 biotech & pharma companies tracked by BioSniper, totaling $12.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$12.8M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 5,203 | $4.8M |
| ABBVAbbVie Inc. | 8,353 | $1.8M |
| AMGNAMGEN INC | 3,365 | $1.2M |
| PRCTPROCEPT BioRobotics Corporation | 45,735 | $1.1M |
| BMYBRISTOL MYERS SQUIBB CO | 11,804 | $716K |
| ABTABBOTT LABORATORIES | 6,881 | $707K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,572 | $702K |
| JNJJOHNSON & JOHNSON | 1,699 | $416K |
| MRKMerck & Co., Inc. | 3,010 | $362K |
| IQVIQVIA Holdings Inc. | 1,595 | $272K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 922 | $250K |
| INSMINSMED Inc | 1,244 | $203K |
| REGNREGENERON PHARMACEUTICALS, INC. | 260 | $201K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.